Although the tumor suppressive effect of rapamycin was thought to be mediated through PI3K/mTOR signaling pathway, our current findings suggest that downregulation of leptin levels may also contribute to the rapamycin-induced pancreatic cancer suppression. The gene discussed is LEP; the disease is neoplasm.